Rhine Biogenics Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 2.97 Cr
as on 23-10-2024
- Company Age 21 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.37 Cr
as on 23-10-2024
- Satisfied Charges ₹ 2.79 Cr
as on 23-10-2024
- Revenue 9.63%
(FY 2023)
- Profit -6.82%
(FY 2023)
- Ebitda -2.49%
(FY 2023)
- Net Worth 24.44%
(FY 2023)
- Total Assets 23.01%
(FY 2023)
About Rhine Biogenics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.97 Cr.
The company currently has active open charges totaling ₹1.37 Cr. The company has closed loans amounting to ₹2.79 Cr, as per Ministry of Corporate Affairs (MCA) records.
Tirunilayi Venugopal, Peter Parriathcherry, Ajith Nair, and Seven other members serve as directors at the Company.
- CIN/LLPIN
U24232KL2003PTC016519
- Company No.
016519
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Oct 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Palakkad, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Rhine Biogenics Private Limited offer?
Rhine Biogenics Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Cosmetics, Hair & Beauty Products, Hair Care Cosmetics, Pharmaceutical Tablets, Flavoxate Tablet, Hair Lotion.
Who are the key members and board of directors at Rhine Biogenics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tirunilayi Venugopal  | Managing Director | 08-Oct-2003 | Current |
Board Members(9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vinod Kumar | Director | 01-Aug-2004 | Current |
| Pudugrammam Vaidyanathan | Director | 08-Oct-2003 | Current |
| Peter Parriathcherry | Director | 17-Nov-2003 | Current |
| Ajith Nair | Director | 17-Nov-2003 | Current |
| Madathiveetil Ramesh | Director | 17-Nov-2003 | Current |
| Kallungal Jothish | Director | 17-Nov-2003 | Current |
Financial Performance and Corporate Structure Insights of Rhine Biogenics.
Rhine Biogenics Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.63% increase. The company also saw a slight decrease in profitability, with a 6.82% decrease in profit. The company's net worth Soared by an impressive increase of 24.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rhine Biogenics?
In 2023, Rhine Biogenics had a promoter holding of 14.85% and a public holding of 85.15%. The company had 1 Subsidiary and 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
R-Vision Eye Hospital Private LimitedActive 5 years 9 monthsTirunilayi Venugopal and Pudugrammam Vaidyanathan are mutual person
Brahmaindic Nutriments Private LimitedActive 7 years 1 monthMadathiveetil Ramesh and Kallungal Jothish are mutual person
Rineus Health Care Company Private LimitedActive 12 years 7 monthsTirunilayi Venugopal, Ajitkumar Warrior and 1 more are mutual person
- Rhine Life Sciences Private LimitedActive 18 years 6 months
Tirunilayi Venugopal, Peter Parriathcherry and 3 more are mutual person
- Renolife Pharma (India) Private LimitedActive 16 years 1 month
Tirunilayi Venugopal, Ajitkumar Warrior and 1 more are mutual person
- Moselle Drugs And Cosmetics LimitedActive 5 years 11 months
Peter Parriathcherry, Reji Joy and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Sep 2022 | ₹2.60 M | Open |
Others Creation Date: 14 Jul 2022 | ₹1.00 M | Open |
Hdfc Bank Limited Creation Date: 04 Mar 2022 | ₹4.20 M | Open |
How Many Employees Work at Rhine Biogenics?
Rhine Biogenics has a workforce of 47 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rhine Biogenics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rhine Biogenics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
